SeaStar Medical Holding Corporation
ICU · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $135 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $135 | $0 | $0 | $0 |
| % Margin | 100% | – | – | – |
| R&D Expenses | $9,105 | $5,973 | $2,503 | $2,766 |
| G&A Expenses | $8,872 | $8,005 | $6,916 | $1,683 |
| SG&A Expenses | $8,872 | $8,037 | $6,916 | $1,683 |
| Sales & Mktg Exp. | $0 | $32 | $0 | $0 |
| Other Operating Expenses | $0 | $200 | $2,190 | $0 |
| Operating Expenses | $17,977 | $14,210 | $11,609 | $4,449 |
| Operating Income | -$17,842 | -$14,210 | -$11,609 | -$4,449 |
| % Margin | -13,216.3% | – | – | – |
| Other Income/Exp. Net | -$6,985 | -$12,022 | -$580 | -$148 |
| Pre-Tax Income | -$24,827 | -$26,232 | -$12,189 | -$4,597 |
| Tax Expense | $3 | $0 | $1 | -$1 |
| Net Income | -$24,830 | -$26,232 | -$12,190 | -$4,596 |
| % Margin | -18,392.6% | – | – | – |
| EPS | -6.63 | -30.263 | -23.38 | -8.81 |
| % Growth | 78.1% | -29.4% | -165.4% | – |
| EPS Diluted | -6.63 | -30.263 | -23.38 | -8.81 |
| Weighted Avg Shares Out | 3,744 | 867 | 521 | 522 |
| Weighted Avg Shares Out Dil | 3,744 | 867 | 521 | 522 |
| Supplemental Information | – | – | – | – |
| Interest Income | $101 | $0 | $1 | $0 |
| Interest Expense | $244 | $1,081 | $630 | $212 |
| Depreciation & Amortization | $0 | $14,010 | $0 | $0 |
| EBITDA | -$24,583 | -$11,141 | -$11,559 | -$4,385 |
| % Margin | -18,209.6% | – | – | – |